Novel Nanoparticle Formulation Fights SCC

Article

Chicago - A novel nanoparticle formulation of paclitaxel (ABI-007) administered intra-arterially has been shown to be well tolerated and very active against squamous carcinomas of the head and neck, uterus, and anal canal, Bruno Damascelli, M.D., said at the 39th annual meeting of the American Society of Clinical Oncology.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.